Abstract:The application of metabolomics in translational research suffers from several technological bottlenecks, such as data reproducibility issues and the lack of standardization of sample profiling procedures. Here, we report an automated high-throughput metabolite array technology that can rapidly and quantitatively determine 324 metabolites including fatty acids, amino acids, organic acids, carbohydrates, and bile acids. Metabolite identification and quantification is achieved using the Targeted Metabolome Batch Quantification (TMBQ) software, the first cross-vendor data processing pipeline. A test of this metabolite array was performed by analyzing serum samples from patients with chronic liver disease (<i>N</i> = 1234). With high detection efficiency and sensitivity in serum, urine, feces, cell lysates, and liver tissue samples and suitable for different mass spectrometry systems, this metabolite array technology holds great potential for biomarker discovery and high throughput clinical testing. Additionally, data generated from such standardized procedures can be used to generate a clinical metabolomics database suitable for precision medicine in next-generation healthcare.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c04686?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c04686</a>.MRM transitions of 3-NPH derivatized metabolites, linearity range, precision, and accuracy (Table S1) (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c04686/suppl_file/ac0c04686_si_001.xlsx">XLSX</a>)UPLC-MS/MS instrument settings (Table S2). Clinical information on study subjects (Table S3). Stability of derivatized analytes in biological sample matrices stored under −80 °C (Table S4). Metabolites identified by TargetLynx (Table S5). Metabolites identified by TMBQ (Table S6). The relative differences of levels of metabolites (mean ± S.D.) identified by TMBQ and TargetLynx (Table S7). The Pearson correlation coefficients of the same metabolites quantified by TMBQ and TargetLynx (Table S8). Quantification results in normal human serum, urine, feces, mouse liver and HepG2 cell samples (Median ± SE) (Table S9). Detected metabolites in the control and liver disease patients (Table S10). Effect of the concentration and quantity of the 3-nitrophenylhydrazine on the chemical derivatization (Figure S1). Effect of the concentration and quantity of the EDC on the 3-nitrophenylhydrazine derivatization (Figure S2). Effect of reaction temperature on the 3-nitrophenylhydrazine derivatization of some selected metabolites (Figure S3). Effect of reaction time on the 3-nitrophenylhydrazine derivatization of some selected metabolites (Figure S4). Typical TIC chromatograms of all 320 metabolite standards (Figure S5). Typical EIC of organic acid standards (Figure S6). Typical EIC of carbohydrates (Figure S7). Typical EIC of bile acid standards (Figure S8). Typical EIC of fatty acid standards (Figure S9). Typical EIC of amino acids and nucleotides (Figure S10). Typical EIC of short chain fatty acids (Figure S11). Workflow and main features of TMBQ (Figure S12). Fragmentation pattern of butyric acid in ESI negative mode as an example (Figure S13). The real metabolite assay kit of the metabolite array used for the analysis of samples in this study (Figure S14). OPLS-DA scores plots of serum metabolite profiles of the controls and liver disease patients and Pie chart showing the chemical classification of the detected metabolites in liver disease patients (Figure S15). 3D scores plot of serum metabolite profiles of (A) HBV patients, fibrosis and cirrhosis patients, and (B) HCC and ICC patients (Figure S16) (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c04686/suppl_file/ac0c04686_si_002.pdf">PDF</a>)This article has not yet been cited by other publications.

Simultaneous quantification of 26 NAD-related metabolites in plasma, blood, and liver tissue using UHPLC-MS/MS

Quantifying the cellular NAD+ metabolome using a tandem liquid chromatography mass spectrometry approach

Absolute quantification of nicotinamide mononucleotide in biological samples by double isotope-mediated liquid chromatography-tandem mass spectrometry (dimeLC-MS/MS)

Development and Validation of an LC-MS/MS Method for Quantifying NAD + and Related Metabolites in Mice Sciatic Nerves and Its Application to a Nerve Injury Animal Model

Optimized protocol for quantification of extracellular nicotinamide adenine dinucleotide: evaluating clinical parameters and pre-analytical factors for translational research

NADomics: Measuring NAD+ and Related Metabolites Using Liquid Chromatography Mass Spectrometry

A liquid chromatography-tandem mass spectrometry based method for the quantification of adenosine nucleotides and NAD precursors and products in various biological samples

Simultaneous Quantification of 11 Pivotal Metabolites in Neural Tube Defects by HPLC-electrospray Tandem Mass Spectrometry.

A proton nuclear magnetic resonance metabonomics approach for biomarker discovery in nonalcoholic fatty liver disease.

Simultaneous 3-Nitrophenylhydrazine Derivatization Strategy of Carbonyl, Carboxyl and Phosphoryl Submetabolome for LC-MS/MS-Based Targeted Metabolomics with Improved Sensitivity and Coverage.

High-throughput and simultaneous quantitative analysis of homocysteine–methionine cycle metabolites and co-factors in blood plasma and cerebrospinal fluid by isotope dilution LC–MS/MS

Miniaturized 1H-NMR method for analyzing limited-quantity samples applied to a mouse model of Leigh disease

Nanoconfined liquid phase nanoextraction combined with in-fiber derivatization for simultaneous quantification of seventy amino-containing metabolites in plasma by LC-MS/MS: Exploration of lung cancer screening model

Simultaneous Determination of Sixteen Metabolites Related to Neural Tube Defects in Maternal Serum by Liquid Chromatography Coupling with Electrospray Tandem Mass Spectrometry.

Plasma NAD(H) Measurement to Monitor Brain Pathophysiology

Meta-analysis of NAD(P)(H) quantification results exhibits variability across mammalian tissues

Simultaneous quantification of niacin and its three main metabolites in human plasma by LC-MS/MS.

The nanomolar sensing of nicotinamide adenine dinucleotide in human plasma using a cycling assay in albumin modified simulated body fluids

A Metabolite Array Technology for Precision Medicine

Development of a fast liquid chromatography-tandem mass spectrometry method for simultaneous quantification of neurotransmitters in murine microdialysate

Novel approach to quantify mitochondrial content and intrinsic bioenergetic efficiency across organs